Technology and health care in an era of limits

Author(s)
    • Institute of Medicine (U.S.). Committee on Technological Innovation in Medicine
    • Howard Hughes Medical Institute
    • Pfizer Inc
    • Health Industry Manufacturers Association
Bibliographic Information

Technology and health care in an era of limits

Annetine C. Gelijns, editor ; Committee on Technological Innovation in Medicine, Institute of Medicine

(Medical innovation at the crossroads, v. 3)

National Academy Press, 1992

Search this Book/Journal
Note

Papers presented at the third Institute of Medicine workshop "The Changing Health Care Economy," held April 18-19, 1991, supported by the Howard Hughes Medical Institute, Pfizer, Inc., and the Health Industry Manufacturers Association

Includes bibliographical references and index

Description and Table of Contents

Description

The U.S. health care system is in a state of flux, and changes currently under way seem capable of exerting sizable effects on medical innovation. This volume explores how the rapid transition to managed care might affect the rate and direction of medical innovation. The experience with technological change in medicine in other nations whose health care systems have "single-payer" characteristics is thoroughly examined. Technology and Health Care in an Era of Limits examines how financing and care delivery strategies affect the decisions made by hospital administrators and physicians to adopt medical technologies. It also considers the patient's stake in the changing health care economy and the need for a stronger independent contribution of patients to the choice of technology used in their care. Finally, the volume explores the impact of changes in the demand for medical technology in pharmaceutical, medical device, and surgical procedure innovation. Table of Contents FRONT MATTER PART I: SETTING THE STAGE PART II: MANAGING CARE IN THE UNITED STATES PART III: MANAGING CARE IN THE UNITED KINGDOM AND CANADA PART IV: IMPLICATIONS FOR PROVIDERS PART V: IMPLICATIONS FOR PATIENTS PART VI: IMPLICATIONS FOR INNOVATORS PART VII: CONCLUDING OBSERVATIONS APPENDIXES INDEX

Table of Contents

  • 1 FRONT MATTER
  • 2 PART I: SETTING THE STAGE
  • 3 PART II: MANAGING CARE IN THE UNITED STATES
  • 4 PART III: MANAGING CARE IN THE UNITED KINGDOM AND CANADA
  • 5 PART IV: IMPLICATIONS FOR PROVIDERS
  • 6 PART V: IMPLICATIONS FOR PATIENTS
  • 7 PART VI: IMPLICATIONS FOR INNOVATORS
  • 8 PART VII: CONCLUDING OBSERVATIONS
  • 9 APPENDIXES
  • 10 INDEX

by "Nielsen BookData"

Related Books: 1-1 of 1
Details
Page Top